医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Acute lymphoblastic leukemia, L2 type (C91.002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Acute lymphoblastic leukemia, L1 type (C91.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Adult Ph-negative acute lymphoblastic leukemia (ALL) (C91.000x023) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
Adult Ph-positive acute lymphoblastic leukemia (ALL) (C91.000x022) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
Acute lymphoblastic leukemia in remission (C91.000x021) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
Pre-T-cell acute lymphoblastic leukemia in remission (C91.000x017) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
T-lymphoblastic leukemia/lymphoma (C91.000x016) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Chronic myeloid leukemia in remission (lymphoid blast crisis) (C91.000x015) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological
Acute lymphoblastic leukemia L3 in remission (C91.000x014) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is b
Acute lymphoblastic leukemia L2 in remission (C91.000x013) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is b
Acute lymphoblastic leukemia L1 in remission (C91.000x012) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is b
B-lymphoblastic leukemia/lymphoma (C91.000x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Pre-T-cell acute lymphoblastic leukemia (C91.000x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Pre-B-cell acute lymphoblastic leukemia (C91.000x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
HHV8-associated multicentric Castleman-disease-derived large B-cell lymphoma (C90.206) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pa
ALK-positive large B-cell lymphoma (C90.205) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Solitary plasma-cell myeloma (C90.204) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Plasma-cell sarcoma (C90.203) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Solitary myeloma (C90.202) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary systemic malignancy of marrow origin; B-cell origin with plasma-cell differentiation. Solitary osseous plasmacytoma rare/curable. Multiple = osteolytic lesions + marrow plasma-cell infiltrate + anemia/hypergammaglobulinemia/hypercalcemia/renal imp
肿瘤内科
|
